News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biodesix, Inc. VeriStrat Study Highlighted in Prominent Series of Oncology Meetings



8/6/2013 7:41:33 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Biodesix, Inc., a fully integrated molecular diagnostic company dedicated to personalizing medicine, today announced that the Phase III clinical trial data for its VeriStrat® test will be a featured abstract in the 2013 Best of ASCO meetings. Topics for the meeting are determined by a panel of medical oncology experts who select abstracts that demonstrate practice-changing science, from the 2013 Annual Meeting of the American Society of Clinical Oncology®. The series visits Chicago, Los Angeles and Boston throughout the month of August.

Hey, check out all the research scientist jobs. Post your resume today!

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES